To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Continuous Renal Replacement Therapy Market size was valued at USD 1.2 Billion in 2021 and is poised to grow from USD 1.38 Billion in 2023 to USD 1.05 Billion by 2030, at a CAGR of 7.38% during the forecast period (2023-2030).

The competitive landscape of the Continuous Renal Replacement Therapy (CRRT) market is characterized by the presence of several key players striving for market dominance. Companies such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Corporation, NxStage Medical, Inc., Infomed SA, Medical Components, Inc., and Bellco S.r.l. are among the prominent players in the market. These companies focus on product innovations, strategic partnerships, mergers and acquisitions, and geographical expansions to gain a competitive edge. Additionally, the market also witnesses the presence of regional players who cater to specific geographical regions, further intensifying the competition. 'Baxter International Inc. - United States', 'Fresenius Medical Care AG & Co. KGaA - Germany', 'B. Braun Melsungen AG - Germany', 'Medtronic plc - Ireland', 'Nikkiso Co., Ltd. - Japan', 'Asahi Kasei Corporation - Japan', 'NxStage Medical, Inc. - United States', 'Infomed SA - Switzerland', 'Medical Components, Inc. - United States', 'Bellco S.r.l. - Italy', 'Toray Medical Co., Ltd. - Japan', 'Medica S.p.A. - Italy', 'Medos Medizintechnik AG - Germany', 'Jafron Biomedical Co., Ltd. - China', 'Nipro Corporation - Japan', 'CytoSorbents Corporation - United States', 'SWS Hemodialysis Care Co., Ltd. - China', 'Aferetica S.r.l. - Italy', 'Terumo Corporation - Japan', 'Shanwaishan Science and Technology (Shenzhen) Co., Ltd. - China'

Increasing Prevalence of Acute Kidney Injury (AKI): The rising incidence of AKI, particularly in critically ill patients and those with underlying health conditions. AKI is commonly observed in settings such as intensive care units, where CRRT is often used as a renal replacement therapy. The growing prevalence of AKI contributes to the demand for CRRT devices and consumables.

The Continuous Renal Replacement Therapy (CRRT) market is experiencing several key market trends. Firstly, there is a growing demand for CRRT devices and consumables due to the increasing prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) globally. The rising geriatric population and the high incidence of comorbidities such as diabetes and hypertension contribute to the demand for CRRT. Secondly, technological advancements are driving the market, with the development of advanced CRRT machines that offer improved efficiency, safety, and user-friendly interfaces. Integration of electronic medical record (EMR) connectivity and remote monitoring capabilities are enhancing patient care and treatment outcomes. Lastly, there is a rising focus on home-based CRRT, allowing patients to receive continuous renal replacement therapy in the comfort of their own homes. This trend is driven by the advantages of home-based therapy, including improved patient convenience, reduced hospital visits, and potentially lower healthcare costs. Overall, these market trends indicate a growing demand for CRRT and a shift towards more advanced and patient-centric treatment approaches.

North America dominated the continuous renal replacement therapy (CRRT) market with the highest revenue share of 35.6% in 2021. The region's market growth is driven by the increasing prevalence of the geriatric population and the rising incidence of kidney disorders. Unhealthy lifestyles and dietary habits, such as sedentary lifestyles and poor eating habits, contribute to the growing incidence of lifestyle-related diseases like kidney dysfunction, hypertension, and diabetes. In the United States, for example, millions of adults are estimated to have chronic kidney disease (CKD), creating a significant demand for CRRT. These factors contribute to the growth of the CRRT market in North America.

Feedback From Our Clients

Continuous renal replacement therapy market

Product ID: SQMIG35A2403

$5,300
BUY NOW